14-day Premium Trial Subscription Try For FreeTry Free

What Is Happening With Endo Shares Today

03:29pm, Wednesday, 18'th May 2022
Endo International Plc (NASDAQ: ENDP) initiated negotiations with its lenders and senior bondholders regarding a possible reorganization of more than $8 billion of its debt, the Wall Street Journa
BMO Capital has decided to maintain its Market Perform rating of Endo International (NASDAQ:ENDP) and lower its price target from $4.00 to $2.00. Shares of Endo International are trading down 14.79% o

Expert Ratings for Endo International

01:48pm, Monday, 09'th May 2022 Benzinga
Endo International (NASDAQ:ENDP) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 1 2 0 La

Endo (ENDP) Beats on Q1 Earnings, Guides Weak Q2 Results

05:23pm, Friday, 06'th May 2022 Zacks Investment Research
Endo (ENDP) tops Q1 earnings and sales estimates. However, Vasostrict faces generic competition and the guidance for Q2 is dismal.

Why Endo International Stock Is Cratering Today

04:16pm, Friday, 06'th May 2022 The Motley Fool
The company provided disappointing Q2 guidance.
Endo (ENDP) tops Q1 earnings and sales estimates. However, Vasostrict faces generic competition and the guidance for Q2 is dismal.
Endo International plc's (NASDAQ: ENDP) Q1 sales decreased 9% to $652.26 million, beating the consensus of $633.41 million. The decrease was attributable to decreased revenues from the sterile injec
The company provided disappointing Q2 guidance.
Endo International plc (NASDAQ:ENDP ) Q1 2022 Earnings Conference Call May 6, 2022 7:30 AM ET Company Participants Laure Park - Senior Vice President, Investor Relations and Corporate Affairs Blaise C
Endo International PLC (NASDAQ: ENDP) shares are trading lower by 34.65% at $1.32 after the company reported first-quarter earnings results and issued second-quarter guidance. Endo International re

Endo International (ENDP) Surpasses Q1 Earnings and Revenue Estimates

11:15pm, Thursday, 05'th May 2022 Zacks Investment Research
Endo (ENDP) delivered earnings and revenue surprises of 50% and 1.73%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Drug/Biotech Stocks Q1 Earnings Due on May 5: VRTX, ZTS & More

07:19pm, Wednesday, 04'th May 2022 Zacks Investment Research
Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.
Let's look at the five biotech/drug companies, slated to release quarterly results on May 5.

Can Endo (ENDP) Keep the Earnings Surprise Streak Alive?

04:10pm, Tuesday, 03'rd May 2022 Zacks Investment Research
Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Endo (ENDP) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE